Home/Filings/4/0001144204-19-000514
4//SEC Filing

Mehren Lawrence 4

Accession 0001144204-19-000514

CIK 0000727207other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 8:32 PM ET

Size

8.3 KB

Accession

0001144204-19-000514

Insider Transaction Report

Form 4
Period: 2019-01-01
Mehren Lawrence
DirectorCEO10% Owner
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-01-01+209,930209,930 total
    Exercise: $11.50Exp: 2029-01-01Common Stock (209,930 underlying)
  • Award

    Employee Stock Option (right to buy)

    2019-01-01$3.31/sh+37,736$124,90637,736 total
    Exercise: $11.50Exp: 2029-01-01Common Stock (37,736 underlying)
Footnotes (3)
  • [F1]The options vest in four (4) equal annual installments on each anniversary of the date of grant beginning on January 1, 2021.
  • [F2]The options vest in twelve (12) equal monthly installments beginning on January 31, 2019.
  • [F3]The options were issued to the reporting person under the 2019 Salary Waiver and Nonqualified Stock Option Grant Plan (the "Sub-Plan") established pursuant to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan. Pursuant to the terms of the Sub-Plan, the reporting person irrevocably waived $125,000 of base compensation scheduled to be paid to the reporting person in 2019 in exchange for such options.

Issuer

Accelerate Diagnostics, Inc

CIK 0000727207

Entity typeother

Related Parties

1
  • filerCIK 0001388833

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:32 PM ET
Size
8.3 KB